We are live on ! Find out more
ANVS icon

Annovis Bio
ANVS

38 hedge funds and large institutions have $36.2M invested in Annovis Bio in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

1.93% less ownership

Funds ownership: 16.01% → 14.08% (-1.9%)

33% less funds holding

Funds holding: 57 → 38 (-19)

67% less capital invested

Capital invested by funds: $109M → $36.2M (-$72.7M)

68% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 28

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
38
Holders Change
-19
Holders Change %
-33.33%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
14
Reduced
10
Closed
28
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
+$5.61M
2
Millennium Management
Millennium Management
New York
+$3.57M
3
WFAG
Wescott Financial Advisory Group
Pennsylvania
+$2.39M
4
Citadel Advisors
Citadel Advisors
Florida
+$2.14M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.56M

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$8.86M
2
EI
EAM Investors
California
-$4.16M
3
ACM
AIGH Capital Management
Maryland
-$3.45M
4
EGI
EAM Global Investors
California
-$2.53M
5
Goldman Sachs
Goldman Sachs
New York
-$2.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
RWM
51
RKL Wealth Management
Pennsylvania
– -$428K -5,000 Closed
Brown Advisory
52
Brown Advisory
Maryland
– -$389K -4,542 Closed
CSS
53
Cubist Systematic Strategies
Connecticut
– -$386K -4,508 Closed
Deutsche Bank
54
Deutsche Bank
Germany
– -$374K -4,367 Closed
BCB
55
Brian C. Broderick
– -$342K -4,000 Closed
Commonwealth Equity Services
56
Commonwealth Equity Services
Massachusetts
– -$339K -3,964 Closed
LPL Financial
57
LPL Financial
California
– -$331K -3,868 Closed
T. Rowe Price Associates
58
T. Rowe Price Associates
Maryland
– -$257K -3,000 Closed
CLCM
59
Crawford Lake Capital Management
New Jersey
– -$237K -2,764 Closed
BLAM
60
Bourne Lent Asset Management
New York
– -$231K -2,700 Closed
GPFA
61
Game Plan Financial Advisors
Ohio
– -$231K -2,700 Closed
BRWA
62
B. Riley Wealth Advisors
Florida
– -$208K -2,430 Closed
US Bancorp
63
US Bancorp
Minnesota
– -$43K -500 Closed
Federated Hermes
64
Federated Hermes
Pennsylvania
– -$2K -19 Closed
MAM
65
McCarthy Asset Management
California
– +$230 +4 +36%
HI
66
Harbour Investments
Wisconsin
– +$345 +6 New
1 2
3

ANVS Hedge Fund Activity: Q3 2021 in Review

38 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q3 2021, worth a combined $36.2M — down 67% from $109M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of ANVS and 9 opened new positions — a net loss of 19 holders — while 10 trimmed existing stakes and 14 added.

The largest buyer was Two Sigma Investments, opening a new position worth an estimated $5.61M. The largest seller was Ikarian Capital, exiting entirely with an estimated $8.86M sold.

  • 38 institutional investors held Annovis Bio (ANVS) as of Q3 2021, down from 57 in Q2 2021.
  • Funds reported $36.2M of Annovis Bio stock for Q3 2021, down 67% quarter-over-quarter.
  • 9 funds opened new Annovis Bio positions in Q3 2021 and 28 closed out, a net change of -19 holders.
  • The largest Annovis Bio buyer in Q3 2021 was Two Sigma Investments, an estimated $5.61M added.
  • The largest Annovis Bio seller in Q3 2021 was Ikarian Capital, an estimated $8.86M sold.

Based on aggregated 13F filings for Q3 2021.